Skip to content
Sign in

ICUI · NASDAQ

ICU Medical (ICUI) Stock Price & Fundamentals

$1,356.23−0.52%−$7.15End-of-day price as of Oct 9, 2026

ICU Medical (ICUI) closed at $1,356.23 on Oct 9, 2026, down 0.52% from the previous close of $1,363.38.

Share price, past year

1Y +29.60%

52-week range $1,018.10 – $1,467.98. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$1,356.23
Sep 30, 2026$1,339.13
Aug 31, 2026$1,424.59
Jul 31, 2026$1,354.76
Jun 30, 2026$1,266.53
May 29, 2026$1,265.12
Apr 30, 2026$1,177.61
Mar 31, 2026$1,096.97
Feb 27, 2026$1,067.80
Jan 30, 2026$1,090.44
Dec 31, 2025$1,083.55
Nov 28, 2025$1,032.28
Oct 31, 2025$1,054.64

Key statistics

Market cap
$33.92B
P/E (TTM)
1,139.7
EPS (TTM)
$1.19
Revenue (TTM)
$2.16B
Net income (TTM)
$30.09M
Shares outstanding
25M
Dividend yield
—
52-week range
$1,018.10 – $1,467.98

ICU Medical's market cap is $33.92B, based on a share price of $1,356.23 and 25M shares outstanding as of Jun 30, 2026.

Financials

ICU Medical reported revenue of $2.23B for fiscal 2025, down 6.33% from fiscal 2024.

ICU Medical earned net income of $732.00K in fiscal 2025, a net margin of 0.0%.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
ICU Medical annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$2.23B−6.3%$732.00K0.0%$0.03$91.80M
FY2024ended Dec 31, 2024$2.38B+5.4%−$117.69M−4.9%−$4.83$124.66M
FY2023ended Dec 31, 2023$2.26B−0.9%−$29.66M−1.3%−$1.23$82.31M
FY2022ended Dec 31, 2022$2.28B+73.2%−$74.29M−3.3%−$3.11−$152.44M
FY2021ended Dec 31, 2021$1.32B+3.6%$103.14M7.8%$4.74$199.00M
FY2020ended Dec 31, 2020$1.27B+0.4%$86.87M6.8%$4.02$130.75M
FY2019ended Dec 31, 2019$1.27B−9.6%$101.04M8.0%$4.69$4.61M
FY2018ended Dec 31, 2018$1.40B+8.3%$28.79M2.1%$1.33$67.50M
FY2017ended Dec 31, 2017$1.29B+240.7%$68.64M5.3%$3.29$79.94M
FY2016ended Dec 31, 2016$379.37M—$63.08M16.6%$3.66$66.58M
ICU Medical quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$551.68M$19.09M$0.76
Q1 FY2026ended Mar 31, 2026$530.23M$30.13M$1.20
Q4 FY2025ended Dec 31, 2025$540.70M−$15.73M−$0.63
Q3 FY2025ended Sep 30, 2025$536.99M−$3.40M−$0.14
Q2 FY2025ended Jun 30, 2025$548.87M$35.34M$1.43
Q1 FY2025ended Mar 31, 2025$604.70M−$15.48M−$0.63
Q4 FY2024ended Dec 31, 2024$629.81M−$23.83M−$0.97
Q3 FY2024ended Sep 30, 2024$589.13M−$32.98M−$1.35

Company profile

Name
ICU Medical, Inc.
Ticker
ICUI
Exchange
NASDAQ
Industry (SEC SIC)
Surgical & Medical Instruments & Apparatus
Headquarters
951 Calle Amanecer, San Clemente, CA 92763-6212
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0000883984

Recent SEC filings

Frequently asked questions

What is ICU Medical's stock price?

ICU Medical (ICUI) closed at $1,356.23 on Oct 9, 2026, down 0.52% from the previous close of $1,363.38.

What is ICU Medical's market cap?

ICU Medical's market cap is $33.92B, based on a share price of $1,356.23 and 25M shares outstanding as of Jun 30, 2026.

How much revenue does ICU Medical make?

ICU Medical reported revenue of $2.23B for fiscal 2025, down 6.33% from fiscal 2024.

What is ICUI's P/E ratio?

ICU Medical's price-to-earnings ratio is 1,139.7, based on trailing twelve-month diluted EPS of $1.19.

Does ICU Medical pay a dividend?

ICU Medical's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from ICU Medical, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures